|Articles|January 27, 2021

Supplements and Featured Publications

  • Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.